Corpus ID: 220936227

What can we learn about SARS-CoV-2 prevalence from testing and hospital data?

  title={What can we learn about SARS-CoV-2 prevalence from testing and hospital data?},
  author={Daniel W Sacks and N. Menachemi and P. Embi and Coady Wing},
  journal={arXiv: Econometrics},
Measuring the prevalence of active SARS-CoV-2 infections is difficult because tests are conducted on a small and non-random segment of the population. But people admitted to the hospital for non-COVID reasons are tested at very high rates, even though they do not appear to be at elevated risk of infection. This sub-population may provide valuable evidence on prevalence in the general population. We estimate upper and lower bounds on the prevalence of the virus in the general population and the… Expand
Estimating the cumulative rate of SARS-CoV-2 infection
Bounding Disease Prevalence by Bounding Selectivity and Accuracy of Tests: The Case of COVID-19
Binary Classification Tests, Imperfect Standards, and Ambiguous Information


Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020
Spread of SARS-CoV-2 in the Icelandic Population
Estimating the burden of SARS-CoV-2 in France
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Performance of Rapid Influenza Diagnostic Testing in Outbreak Settings
Estimating the Covid-19 Infection Rate: Anatomy of an Inference Problem
Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020
  • T. Russell, J. Hellewell, +7 authors A. Kucharski
  • Medicine
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2020